Intraparasitic heme and ferrous iron

The entity "Intraparasitic heme and ferrous iron" does not refer to a single protein, receptor, or enzyme, but rather denotes a class of chemically reactive molecules—specifically, free (labile) heme and ferrous iron—within parasite-infected cells, most notably during malaria infection. During hemoglobin digestion by malaria parasites within red blood cells, large amounts of **free heme** (iron–protoporphyrin IX, Fe2+ form) and **ferrous iron (Fe2+)** are released[2]. Both are highly redox-active and can mediate the generation of toxic reactive oxygen species, which is utilized by some antimalarial drugs—such as artemisinin and 1,2,4-trioxolane fragments—which are activated by these molecules to produce cytotoxic effects against the parasite[1][2]. Parasites detoxify heme by converting it into an inert crystalline form, hemozoin; failure to do so leads to oxidative damage and cell death. Because "Intraparasitic heme and ferrous iron" refers to small, labile molecules rather than a druggable protein or a canonical biological target, it is not formally classified as a therapeutic target (receptor, enzyme, etc.), though it is a **druggable context** exploited by antimalarial drug design[1][2][5]. **Note**: This entry is flagged as *is_incorrect* because it refers to a biochemical context, not a distinct, canonical drug target. It should not be treated as equivalent to a protein, enzyme, or receptor; rather, it represents a cellular vulnerability in the parasite exploited by certain drug classes.

Other names

heme (intra-parasitic)ferrous iron (intra-parasitic)labile heme iron

Activation of antimalarial drugs via *redox reaction* (artemisinin, trioxolanes) exploiting free ferrous iron or heme and generating cytotoxic radicals within the parasite[2][1] Detoxification by sequestration (hemozoin formation) to avoid oxidative stress